Sakari Simula1, Tomi P Laitinen2, Tiina M Laitinen2, Päivi Hartikainen3, Juha E K Hartikainen4. 1. Department of Neurology, Mikkeli Central Hospital, Mikkeli, Finland. 2. Department of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital and University of Eastern Finland, Kuopio, Finland. 3. Neuro Center, Kuopio University Hospital and University of Eastern Finland, Kuopio, Finland. 4. Heart Center, Kuopio University Hospital and University of Eastern Finland, Kuopio, Finland.
Abstract
BACKGROUND: Homeostasis between heart rate and blood pressure is based on several interacting regulatory reflexes, which become influenced by fingolimod initiation. The aim of this study was to determine the sequence of changes in cardiovascular autonomic regulation after fingolimod initiation. METHODS: Twenty-seven patients with relapsing-remitting multiple sclerosis underwent continuous electrocardiogram recording during the first 6 hr after the first dose of fingolimod. In addition to the time interval between two consecutive R-peaks (RR interval), blood pressure and heart rate variability (HRV) were measured on hourly basis. Cardiac parasympathetic and sympathetic regulation were assessed by the different components of HRV. RESULTS: HRV demonstrated an enhancement in cardiac parasympathetic regulation starting 1 hr after the first dose of fingolimod. Blood pressure started to decrease 2 hr and sympathetic cardiac regulation 3 hr after fingolimod initiation. Recovery in RR interval, systolic and diastolic blood pressure, as well as in cardiac autonomic regulation started after 5 hr postdose, whereas pulse pressure (difference between systolic and diastolic blood pressure) continued to increase at the time of hospital discharge. CONCLUSIONS: RR interval, blood pressure, as well as the parasympathetic and sympathetic components of cardiac autonomic regulation alter sequentially in different temporal pattern after fingolimod initiation. These findings enhance the understanding of the effects of fingolimod initiation on cardiovascular autonomic regulation in real life.
BACKGROUND: Homeostasis between heart rate and blood pressure is based on several interacting regulatory reflexes, which become influenced by fingolimod initiation. The aim of this study was to determine the sequence of changes in cardiovascular autonomic regulation after fingolimod initiation. METHODS: Twenty-seven patients with relapsing-remitting multiple sclerosis underwent continuous electrocardiogram recording during the first 6 hr after the first dose of fingolimod. In addition to the time interval between two consecutive R-peaks (RR interval), blood pressure and heart rate variability (HRV) were measured on hourly basis. Cardiac parasympathetic and sympathetic regulation were assessed by the different components of HRV. RESULTS: HRV demonstrated an enhancement in cardiac parasympathetic regulation starting 1 hr after the first dose of fingolimod. Blood pressure started to decrease 2 hr and sympathetic cardiac regulation 3 hr after fingolimod initiation. Recovery in RR interval, systolic and diastolic blood pressure, as well as in cardiac autonomic regulation started after 5 hr postdose, whereas pulse pressure (difference between systolic and diastolic blood pressure) continued to increase at the time of hospital discharge. CONCLUSIONS: RR interval, blood pressure, as well as the parasympathetic and sympathetic components of cardiac autonomic regulation alter sequentially in different temporal pattern after fingolimod initiation. These findings enhance the understanding of the effects of fingolimod initiation on cardiovascular autonomic regulation in real life.
Authors: S Rossi; C Rocchi; V Studer; C Motta; B Lauretti; G Germani; G Macchiarulo; G A Marfia; D Centonze Journal: Mult Scler Date: 2014-06-23 Impact factor: 6.312
Authors: Peter A Calabresi; Ernst-Wilhelm Radue; Douglas Goodin; Douglas Jeffery; Kottil W Rammohan; Anthony T Reder; Timothy Vollmer; Mark A Agius; Ludwig Kappos; Tracy Stites; Bingbing Li; Linda Cappiello; Philipp von Rosenstiel; Fred D Lublin Journal: Lancet Neurol Date: 2014-03-28 Impact factor: 44.182
Authors: Sakari Simula; Tomi Laitinen; Tiina M Laitinen; Tuula Tarkiainen; Päivi Hartikainen; Juha Ek Hartikainen Journal: Mult Scler Date: 2015-09-11 Impact factor: 6.312
Authors: Oliver Monfredi; Alexey E Lyashkov; Anne-Berit Johnsen; Shin Inada; Heiko Schneider; Ruoxi Wang; Mahesh Nirmalan; Ulrik Wisloff; Victor A Maltsev; Edward G Lakatta; Henggui Zhang; Mark R Boyett Journal: Hypertension Date: 2014-09-15 Impact factor: 10.190
Authors: Max J Hilz; Tassanai Intravooth; Sebastian Moeller; Ruihao Wang; De-Hyung Lee; Julia Koehn; Ralf A Linker Journal: PLoS One Date: 2015-07-06 Impact factor: 3.240
Authors: Sakari Simula; Tomi P Laitinen; Tiina M Laitinen; Päivi Hartikainen; Juha E K Hartikainen Journal: Ann Noninvasive Electrocardiol Date: 2017-02-13 Impact factor: 1.468
Authors: Wojciech Zareba; Sally W Thurston; Grazyna Zareba; Jean Philippe Couderc; Katie Evans; Jean Xia; Gene E Watson; J J Strain; Emeir McSorley; Alison Yeates; Maria Mulhern; Conrad F Shamlaye; Pascal Bovet; Edwin van Wijngaarden; Philip W Davidson; Gary J Myers Journal: Neurotoxicol Teratol Date: 2019-05-23 Impact factor: 3.763